Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A repair pathway lost in multiple sclerosis provides a new drug opportunity.

Journal article

Jensen LT. et al, (2024), Nat Immunol, 25, 385 - 386

Ancient DNA reveals evolutionary origins of autoimmune diseases.

Journal article

Barrie W. et al, (2024), Nat Rev Immunol

Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations.

Journal article

Barrie W. et al, (2024), Nature, 625, 321 - 328

The selection landscape and genetic legacy of ancient Eurasians.

Journal article

Irving-Pease EK. et al, (2024), Nature, 625, 312 - 320

Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors.

Journal article

Jensen LT. et al, (2023), EBioMedicine, 97

Identification of early neurodegenerative pathways in progressive multiple sclerosis.

Journal article

Kaufmann M. et al, (2022), Nat Neurosci

The immunology of multiple sclerosis.

Journal article

Attfield KE. et al, (2022), Nat Rev Immunol

MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19.

Journal article

Francis A. et al, (2022), Lancet Neurol, 21, 217 - 218

Inflammation-related plasma and CSF biomarkers for multiple sclerosis.

Journal article

Huang J. et al, (2020), Proc Natl Acad Sci U S A

A novel neurodegenerative spectrum disorder in patients with MLKL deficiency.

Journal article

Faergeman SL. et al, (2020), Cell Death Dis, 11

HLA variation and disease.

Journal article

Dendrou CA. et al, (2018), Nat Rev Immunol, 18, 325 - 339

The Human Cell Atlas.

Journal article

Regev A. et al, (2017), Elife, 6

Immunomodulation in multiple sclerosis: promises and pitfalls.

Journal article

Dendrou CA. and Fugger L., (2017), Curr Opin Immunol, 49, 37 - 43

Structural and regulatory diversity shape HLA-C protein expression levels.

Journal article

Kaur G. et al, (2017), Nat Commun, 8

Load More